These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1374683

  • 1. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
    Gazitt Y, He YJ, Chang L, Koza S, Fisk D, Graham-Pole J.
    Cancer Res; 1992 May 15; 52(10):2957-65. PubMed ID: 1374683
    [Abstract] [Full Text] [Related]

  • 2. A novel methodology for the establishment of neuroblastoma cell lines from metastatic marrow. Expression of surface markers, neurofilaments, MDR-1 and myc proteins.
    Gazitt Y, He YJ, Graham-Pole J.
    J Immunol Methods; 1992 Apr 08; 148(1-2):171-8. PubMed ID: 1348778
    [Abstract] [Full Text] [Related]

  • 3. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
    Chassevent A, Bénard J.
    Bull Cancer; 1997 Mar 08; 84(3):29-34. PubMed ID: 9207866
    [Abstract] [Full Text] [Related]

  • 4. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A.
    Oncogene; 1988 Oct 08; 3(4):429-35. PubMed ID: 3152600
    [Abstract] [Full Text] [Related]

  • 5. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 6. Ultrastructural localization and fluctuation in the level of the proliferating cell nuclear antigen and myc oncoproteins in synchronized neuroblastoma cells.
    Gazitt Y, Erdos GW, Cohen RJ.
    Cancer Res; 1993 Apr 15; 53(8):1899-905. PubMed ID: 8096797
    [Abstract] [Full Text] [Related]

  • 7. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA, Lazarova DL, Ross RA, Biedler JL.
    Oncol Res; 1997 Apr 15; 9(9):467-76. PubMed ID: 9495452
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 9. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J.
    Cancer Res; 1991 Jan 01; 51(1):33-6. PubMed ID: 1988094
    [Abstract] [Full Text] [Related]

  • 10. Coexpression of the myc gene family members in human neuroblastoma cell lines.
    Hemmi H, Yamada K, Yoon UH, Kato M, Taniguchi F, Tsuchida Y, Shimatake H.
    Biochem Mol Biol Int; 1995 Aug 01; 36(6):1135-41. PubMed ID: 8535284
    [Abstract] [Full Text] [Related]

  • 11. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD.
    Cancer Res; 1994 Oct 01; 54(19):5036-40. PubMed ID: 7923112
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T, Scholz RB, Milde-Langosch K, Heinsohn S, Löning T, Kabisch H.
    Cancer Detect Prev; 1992 Oct 01; 16(3):185-92. PubMed ID: 1458508
    [Abstract] [Full Text] [Related]

  • 14. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM.
    Oncogene; 1990 Dec 01; 5(12):1821-7. PubMed ID: 2284101
    [Abstract] [Full Text] [Related]

  • 15. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P, Bains MA, Watson R, Fisher J, Hoy TG, Jacobs A.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [Abstract] [Full Text] [Related]

  • 16. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W, Schwab M.
    Oncogene; 1997 Jul 17; 15(3):303-15. PubMed ID: 9233765
    [Abstract] [Full Text] [Related]

  • 17. Electron microscopic localization of acridine orange binding to euchromatin in human neuroblastoma cells.
    Hiroi M, Moriki T, Taniguchi T, Yamane T, Lehmann R, Hara H.
    Zentralbl Pathol; 1991 Jul 17; 137(1):20-8. PubMed ID: 1905567
    [Abstract] [Full Text] [Related]

  • 18. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J, Chattopadhyay B, Venkatakrishnan G, Ross AH.
    Cell Growth Differ; 1990 Feb 17; 1(2):79-85. PubMed ID: 1964795
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of the proto-oncogene, c-myc, in human neuroblastoma cells by reversible inhibition of cell growth.
    Fukuchi K, Tomoyasu S, Watanabe K, Suzuki H, Kaetsu T, Takagi Y, Tsuruoka N, Gomi K.
    Anticancer Res; 1991 Feb 17; 11(6):1967-73. PubMed ID: 1776829
    [Abstract] [Full Text] [Related]

  • 20. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L, Tonini GP.
    Anticancer Res; 1990 Feb 17; 10(4):897-902. PubMed ID: 1974410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.